Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) is a publicly traded Healthcare sector company. As of May 21, 2026, MDGL trades at $516.50 with a market cap of $12.04B and a P/E ratio of -39.89. MDGL moved +0.31% today. Year to date, MDGL is -12.73%; over the trailing twelve months it is +75.39%. Its 52-week range spans $200.63 to $615.00. Analyst consensus is strong buy with an average price target of $674.25. Rallies surfaces MDGL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. MDGL moved +0.31% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $516.50 |
| Market Cap | $12.04B |
| P/E Ratio | -39.89 |
| EPS | $-12.85 |
| Dividend Yield | 0.00% |
| 52-Week High | $615.00 |
| 52-Week Low | $200.63 |
| Volume | 235.88K |
| Avg Volume | 0 |
| Revenue (TTM) | $958.40M |
| Net Income | $-288.28M |
| Gross Margin | 0.00% |
8 analysts cover MDGL: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $674.25.